It’s all good news, really. If Prurisol delivers quality results, kaboom ;-). If not, we see a short lived drop followed by a Brilacidin deal. And ipix moves into the future. Though I’d love to see the B deal before P results.
DaubersUP, if we achieve Pase 75 at 35% or higher, IPIX will be a huge winner with this one drug alone. I think we'll do much better than that. My guess is that the healing that Nerby recounted based upon his communication with one trial participant will turn out not to be unique. I'm looking forward to news that will change the complexion (pun intended) of our investment overnight.
News 
Market Data 
Discover 
AI
